Global Fund to Fight AIDS, Tuberculosis and Malaria’s “Voices”: From Davos, the Power of Public-Private Partnerships
Christoph Benn, director of external relations at the Global Fund, discusses the role of public-private partnerships in global health, highlighting partnership announcements made at the World Economic Forum in Davos this week. Benn writes, “Three of the world’s leading private companies in their fields — Lombard Odier, HEINEKEN, and Unilever — announced partnership agreements with the Global Fund toward a common goal: improving public health and ending HIV, tuberculosis, and malaria as epidemics. These partnerships further underline the pivotal role the private sector can play in advancing global health to protect communities from infectious diseases and halt emerging health threats” (1/26).

Global Fund to Fight AIDS, Tuberculosis and Malaria: Lombard Odier and the Global Fund Join Forces to Expand Private Investment In Global Health
“Lombard Odier and the Global Fund are pleased to announce a strategic partnership to rethink traditional approaches to investment and philanthropy to make it easier for more people to contribute to the fight against some of the world’s most pressing health challenges. Together they will create innovative solutions that allow investors to meet both their goals of doing well financially and doing good socially. … The partnership with Lombard Odier will look for ways to help the private sector contribute to the Global Fund’s vital work, while addressing investors’ need to meet their financial goals…” (1/26).

HEINEKEN: Global Fund and HEINEKEN Enter Into Partnership to Fight Against Infectious Diseases in Africa
“The Global Fund and HEINEKEN [Friday] launched a new partnership, joining forces to further advance a common goal: ending HIV, tuberculosis, and malaria as epidemics in Africa. As part of the partnership, HEINEKEN will lend its expertise in the areas of logistics and communications to support the Global Fund in better reaching specific demographic groups that are most at risk of HIV, tuberculosis, and malaria…” (1/26).